Markets › LSE › BVXP.L

Bioventix PLC

LSE:BVXP.LHealthcareFTSE:AXX

£20.18+0.90%Delayed 15 minIn session · ≈ AED 99.26 · Market cap $137.68M · Next earnings Mon 26 Oct

Ratio	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	Current · undated	YoY
Gross margin	90.7%	91.3%	92.7%	92.5%	93.2%	90.9%	—	—
Operating margin	77.2%	74.0%	79.1%	78.4%	77.9%	75.5%	75.5%	+0.0 pts
Net margin	69.8%	61.6%	65.5%	65.3%	59.5%	57.8%	57.8%	+0.0 pts
EBITDA margin	78.7%	75.2%	80.4%	79.6%	78.9%	77.5%	—	—
Return on equity	57.5%	56.9%	64.9%	69.4%	67.5%	65.7%	65.7%	+0.0 pts
Return on assets	54.2%	52.2%	58.5%	63.0%	59.0%	59.0%	59.0%	+0.0 pts
Return on capital employed	63.3%	68.0%	78.2%	83.1%	88.3%	85.7%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—
Debt / assets	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—
Interest coverage	0.0×	0.0×	30,605.7×	0.0×	0.0×	0.0×	—	—
Current ratio	16.4×	11.4×	9.4×	10.1×	7.4×	9.2×	9.2×	+0.0%
Quick ratio	16.1×	11.0×	9.1×	9.6×	7.1×	8.6×	—	—
Cash ratio	11.1×	6.4×	4.9×	4.8×	3.5×	3.9×	3.9×	+0.0%
Asset turnover	0.8×	0.8×	0.9×	1.0×	1.0×	1.0×	—	—
Inventory turnover	3.9×	2.9×	1.8×	1.7×	1.5×	1.7×	—	—
Receivables turnover	2.8×	2.4×	2.2×	2.2×	2.2×	2.1×	—	—
Dividend payout	90.3%	114.5%	103.2%	100.8%	101.9%	108.0%	—	—